Insider Trading & Ownership of Gregory Gene Freitag

Location
Alachua, FL
Summary
The estimated net worth of Gregory Gene Freitag is at least $2,420,909 dollars as of 03 Mar 2026. Gregory Gene Freitag is the Director of Axogen, Inc. and owns shares of Axogen, Inc. (AXGN) stock worth about $2.32M. Gregory Gene Freitag is the Director of PDS Biotechnology Corp and owns shares of PDS Biotechnology Corp (PDSB) stock worth about $101.6K.
Signature
/s/ Spencer Brown, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Gregory Gene Freitag and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Gregory Gene Freitag has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,420,909.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Axogen, Inc. ($2,319,295).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Gregory Gene Freitag

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AXGN Axogen, Inc. Director $2,319,295 04 Jun 2024
PDSB PDS Biotechnology Corp Director $101,614 12 Jan 2026
ZVSA ZyVersa Therapeutics, Inc. Director 11 Jul 2025

Insider Transactions Reported by Gregory Gene Freitag:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .